CSIMarket
 
Angiodynamics Inc   (NASDAQ: ANGO)
 
Price: $15.2800 $0.04 0.262%
Day's High: $15.470000267028809 Week Perf: 0.53 %
Day's Low: $ 15.06 30 Day Perf: -2.98 %
Volume (M): 80,827 52 Wk High: $ 16.29
Volume (M$): $ 0 52 Wk Avg: $12.15
Open: $15.44 52 Wk Low: $9.39



 Market Capitalization (Millions $) 635
 Shares Outstanding (Millions) 42
 Employees 632
 Revenues (TTM) (Millions $) 318
 Net Income (TTM) (Millions $) -37
 Cash Flow (TTM) (Millions $) -18
 Capital Exp. (TTM) (Millions $) 7

Business Description


AngioDynamics Inc is a leading provider of innovative medical technologies and devices for minimally-invasive surgical procedures that are used in hospitals, clinics, and physician offices worldwide. The company's product portfolio includes medical devices that are designed to diagnose, treat, and manage a wide range of medical conditions, including peripheral vascular disease, cancer, and other serious medical conditions.

AngioDynamics was founded in Queensbury, New York, in 1988, and has since grown to become a global medical technology company. The company operates in more than 60 countries and employs over 1,400 people worldwide. The company's headquarters is located in Latham, New York.

The product portfolio of AngioDynamics includes a variety of medical devices and technologies that are used in interventional procedures including:

1. Peripheral Vascular Interventions: AngioDynamics offers a variety of products to diagnose and treat peripheral artery disease. These include the market-leading VenaCure EVLT laser system for treatment of varicose vein and the AngioVac cannula and circuit for extraction of clot in various vascular procedures.

2. Oncology: AngioDynamics provides a variety of technologies to diagnose and treat cancer, including the NanoKnife Irreversible Electroporation System, which uses electrical pulses to kill cancer cells.

3. Interventional Radiology: AngioDynamics' interventional radiology products include the BioFlo PICC, which is designed to reduce complications associated with central venous catheterization and the Bioflo Port, a power-injected, long-term use catheter.

4. Surgical Oncology: AngioDynamics offers a variety of products for surgical oncology, including radiofrequency ablation (RFA), microwave ablation, and cryoablation systems for the treatment of solid tumors.

In addition to its product portfolio, AngioDynamics also has a strong focus on research and development. The company invests a significant amount of resources in the development of new technologies and devices for minimally-invasive surgical procedures.

AngioDynamics has a strong reputation for quality and innovation, and its products are used by medical professionals across the globe. With its broad portfolio of medical technologies, AngioDynamics is well-positioned to continue growing and advancing the field of minimally-invasive surgical procedures.


   Company Address: 14 Plaza Drive Latham 12110 NY
   Company Phone Number: 795-1400   Stock Exchange / Ticker: NASDAQ ANGO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BDX   -6.1%    
EW   -5.11%    
MDT   -2.35%    
SYK   -12.49%    
TFX   -7.75%    
ZBH   -6.52%    
• View Complete Report
   



Business Update

LATHAM, N.Y. AngioDynamics, Inc. (NASDAQ ANGO), a prominent medical technology company committed to enha...

Published Mon, Oct 13 2025 7:41 PM UTC

AngioDynamics NanoKnife System Recognised in TIME’s 2025 Best Inventions List LATHAM, N.Y. AngioDynamics, Inc. (NASDAQ: ANGO), a prominent medical technology company committed to enhancing vascular health and cancer treatment options, has received notable recognition for its innovative NanoKnife System, which has been included in TIME’s 2025 Best Inventions List. This...

Business Update

AngioDynamics Innovates & Excels FDA Greenlights NanoKnife for Prostate Cancer Amidst Financial Accolades,

Published Tue, Dec 31 2024 1:30 PM UTC

AngioDynamics Triumphs: FDA Clears Innovative NanoKnife System for Prostate Treatment Amid Financial Prowess In a significant stride for medical innovation, AngioDynamics, Inc. (NASDAQ: ANGO), a dynamic player in the medical technology domain, has announced its recent achievement of the U.S. Food and Drug Administration (FDA) 510(k) clearance for their cutting-edge NanoKnife...

Business Update

AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18 System in Treatment of Pulmonary Embolism an...

Published Fri, Sep 20 2024 12:47 AM UTC

Breaking Ground in Pulmonary Embolism Treatment: AngioDynamics Initiates Pioneering RECOVER-AV Clinical Trial Latham, N.Y. AngioDynamics, Inc. (NASDAQ: ANGO), a leading figure in transformative medical technology focused on vascular health, cancer treatment, and enhancing patient quality of life, has announced the initiation of the RECOVER-AV clinical trial. This groundbr...

Business Update

AngioDynamics Unveils Pioneering Clinical Endeavor for Thrombotic Treatment Amidst Financial Setbacks

Published Thu, Sep 19 2024 11:47 PM UTC

In the ever-evolving realm of medical technology, where innovation coalesces with the poignant demands of therapeutic efficacy, AngioDynamics, Inc. a venerable entity listed on the NASDAQ under the ticker ANGO, has recently taken a bold stride. This audacious initiative heralds the commencement of the RECOVER-AV clinical trial, primarily aimed at evaluating the AlphaVac F18 ...

Business Update

AngioDynamics Secures CE Mark for Auryon Atherectomy System, Advancing Treatment for Peripheral Artery Disease in Eur...

Published Tue, Sep 3 2024 1:47 PM UTC

AngioDynamics, Inc. a prominent medical technology company renowned for its innovations in vascular health, announced on Monday that it has received CE Mark approval in Europe for its Auryon Atherectomy System. This system is particularly significant for the treatment of Peripheral Artery Disease (PAD), which affects millions of people worldwide, impairing blood flow to the ...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 2.00
Price to Sales (Expected) -
Price to Book 3.71
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.72
Working Capital Ratio 2.24
Leverage Ratio (MRQ) 0.56
Total Debt to Equity -
Interest Coverage (TTM) 278.76
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.87 $
Revenues (TTM) 7.65 $
Cash Flow (TTM) -
Cash 1.3 $
Book Value 4.11 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 502,731
Net Income per Employee (TTM) -58,136
Receivable Turnover Ratio (TTM) 7.08
Inventory Turnover Ratio (TTM) 2.43
Asset Turnover Ratio (TTM) 1.11

Profitability Ratios Current
Gross Margin (MRQ) 54.01 %
Operating Margin (MRQ) -11.77 %
Net Margin (MRQ) -13.17 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Angiodynamics Inc's Segments
Med Tech    173.14 % of total Revenue
Med Device    196.54 % of total Revenue
United States    317.44 % of total Revenue
Non-US    52.25 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.